Vels Film (VELS)
Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹58 |
| Market Cap | ₹74.87 Cr |
| P/E Ratio | 3.53 |
| ROCE | 0.14% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 50.87% |
| Debt/Equity | — |
| Sales Growth | -90.57% |
| Promoter Holding | 74.33% |
| 52-Week Range | ₹45.35 — ₹75 |
| Sector | Entertainment |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At first glance, a P/E of 3.53 and a PEG of 0.07 look like a deep value bargain. But Benjamin Graham taught me to look behind the numbers, not at them. Vels Film's latest quarter tells a far more troubling story: sales of just ₹1 crore and a net loss of ₹5 crore. A company with 74.33% promoter holding and a market cap of ₹65 crore sounds closely held, but that alone provides no margin of safety. The sales growth figure of -90.57% is alarming. This is not a temporary stumble; it is a near-total evaporation of revenue. The reported profit growth of +50.87% is meaningless when the base has collapsed and the most recent quarter shows a loss. ROCE of 0.14% confirms that the business is generating almost no return on capital employed. With no dividend, no book value, no return on equity, and inadequate data for a FairStock score, I cannot value this as a going concern on any conventional basis. Perhaps this is a cyclical film business awaiting a hit, or a special-situation turnaround. But the latest quarter's ₹1 crore sales against a ₹65 crore market cap implies a staggeringly high price-to-sales ratio. The film industry is inherently hit-driven and unpredictable; a 'cheap' stock can become cheaper when the next release fails. I would need credible evidence of a film pipeline, steady revenue recovery, and a return to positive net profit before even considering an investment. Until then, this is not an investment; it is a speculation.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer